New York State Common Retirement Fund’s iBio IBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4
Closed 3356
2022
Q2
$0 Sell
4
-251
-98% -$37.7K ﹤0.01% 3507
2022
Q1
$55K Hold
255
﹤0.01% 3148
2021
Q4
$70K Sell
255
-1
-0.4% -$381 ﹤0.01% 3157
2021
Q3
$135K Buy
256
+2
+0.8% +$1.25K ﹤0.01% 3042
2021
Q2
$192K Buy
254
+18
+8% +$13.1K ﹤0.01% 3058
2021
Q1
$182K Buy
236
+29
+14% +$25.3K ﹤0.01% 2873
2020
Q4
$109K Buy
207
+118
+133% +$96.1K ﹤0.01% 2990
2020
Q3
$90K Sell
89
-35
-28% -$50.7K ﹤0.01% 2969
2020
Q2
$138K Buy
+124
New +$81.1K ﹤0.01% 2811

Other funds holding IBIO

New York State Common Retirement Fund's IBIO Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of iBio (IBIO) in Q3 2022, closing a stake of 4 shares.

New York State Common Retirement Fund first reported a position in IBIO in Q2 2020 and held it in 9 quarters. The position peaked at $192K in Q2 2021. 43 funds tracked by Wall St. Rank hold IBIO as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining iBio position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 4 iBio shares in Q3 2022.
  • New York State Common Retirement Fund first reported a position in iBio in Q2 2020 and held it in 9 quarters.
  • New York State Common Retirement Fund's iBio position peaked at $192K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held iBio as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.